PPARγ Expression in Human Spermatozoa and Its Relationship with Seminal F2-Isoprostanes and Resolvin D1 in the Presence of Varicocele and Urogenital Infections
- PMID: 40001905
- PMCID: PMC11851876
- DOI: 10.3390/biology14020137
PPARγ Expression in Human Spermatozoa and Its Relationship with Seminal F2-Isoprostanes and Resolvin D1 in the Presence of Varicocele and Urogenital Infections
Abstract
Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) is a regulating agent in antioxidant response also involved in controlling inflammation. The impact of varicocele and urogenital infections on sperm PPARγ expression was studied. The PPARγ gene expression was investigated in spermatozoa of 26 normozoospermic men grouped according to their clinical conditions: normal semen parameters (N), normal semen parameters and varicocele (N + V), and normal semen parameters and urogenital infections (N + UI). Sperm PPARγ expression was correlated with F2-isoprostanes (F2-IsoPs), as markers of lipid peroxidation, and Resolvin D1 (RvD1), a pro-resolving mediator in inflammation. Sperm PPARγ expression was evaluated through comparative real-time PCR, and F2-IsoPs and RvD1 were quantified in the seminal plasma via GC/NCI-MS/MS and immunoassay, respectively. PPARγ expression correlates positively with sperm morphology and vitality and negatively with F2-IsoPs and RvD1. Sperm morphology positively correlates with vitality and negatively with F2-IsoP and RvD1 levels. Despite the normozoospermia in the three examined groups, sperm morphology and PPARγ expression were significantly reduced in N + V and N + UI groups compared to the N group. Additionally, F2-IsoP and RvD1 levels were elevated in N + V and N + UI patients. These data suggest that PPARγ expression is compromised by inflammation and lipoperoxidation, providing new insights to further explore new possibilities of targeted treatment of male infertility.
Keywords: F2-isoprostanes; PPARγ expression; human spermatozoa; normozoospermia; resolvin D1; urogenital infections; varicocele.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures

Similar articles
-
Are F2-isoprostanes a better marker of semen lipid peroxidation than MDA in reproductive pathologies with inflammatory basis?Cytokine. 2025 Apr;188:156889. doi: 10.1016/j.cyto.2025.156889. Epub 2025 Feb 8. Cytokine. 2025. PMID: 39923300
-
Seminal F2-IsoP and RvD1 Levels in Idiopathic Infertile Men.Biology (Basel). 2025 Apr 21;14(4):450. doi: 10.3390/biology14040450. Biology (Basel). 2025. PMID: 40282315 Free PMC article.
-
A Study to Validate the Relevance of Semen F2-Isoprostanes on Human Male Infertility.Int J Environ Res Public Health. 2022 Jan 31;19(3):1642. doi: 10.3390/ijerph19031642. Int J Environ Res Public Health. 2022. PMID: 35162677 Free PMC article.
-
Unresolved issues in the analysis of F2-isoprostanes, F4-neuroprostanes, isofurans, neurofurans, and F2-dihomo-isoprostanes in body fluids and tissue using gas chromatography/negative-ion chemical-ionization mass spectrometry.Free Radic Res. 2015;49(7):861-80. doi: 10.3109/10715762.2015.1014812. Epub 2015 Mar 27. Free Radic Res. 2015. PMID: 25812589 Review.
-
Role of isoprostanes in human male infertility.Syst Biol Reprod Med. 2020 Oct;66(5):291-299. doi: 10.1080/19396368.2020.1793032. Epub 2020 Aug 25. Syst Biol Reprod Med. 2020. PMID: 32842780 Review.
References
-
- Mousavi M.S., Shahverdi A., Drevet J., Akbarinejad V., Esmaeili V., Sayahpour F.A., Topraggaleh T.R., Rahimizadeh P., Alizadeh A. Peroxisome Proliferator-Activated Receptors (PPARs) levels in spermatozoa of normozoospermic and asthenozoospermic men. Syst. Biol. Reprod. Med. 2019;65:409–419. doi: 10.1080/19396368.2019.1677801. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous